Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Omar El Muhanna

Executive-MBA, BSc. Engineering

Senior Operations Manager, the Clinical Biomanufacturing Facility

Omar is a senior executive with a proven track record of creating long-term value in complex international operations and business management. He is best known for his successful handling of the Oxford/AstraZeneca COVID-19 vaccine emergency response operation, which involved the biomanufacturing and global distribution to clinical trials. His expertise in complex operations was pivotal to this effort, and he is a recognised contributor to the Intellectual Property (IP) licensed by Oxford University Innovation to AstraZeneca. 

Omar has extensive experience in the international affairs and humanitarian aid industry. In previous roles, he played a major part in initiating, designing, and implementing the first Informal Cross-Border humanitarian assistance operation into Syria during extremely challenging circumstances. He has also led an over 500 staff organization merger and over $80 million budget.

 As a growth and impact-driven strategist and corporate finance expert, Omar has developed profit and non-profit business models, controlled diverse sources of funds, compliance requirements, organically-funded income-generating and grant-funded operations. He is a multilinguist with an Executive-MBA degree from the Kellogg School of Management, Northwestern University. His heightened problem-solving, data analytics, and critical thinking skills have enabled him to lead innovative processes and optimize high-performance teams with diverse positive work cultures for the successful delivery of revenue growth and cost reductions.

 Omar leveraged the vaccine's success by establishing strategic networking and partnerships with the industry to expand reach for accelerated growth and diversifying customer portfolios and revenue streams. Currently, he is playing a major role in leading a £15 million capital project to accommodate an additional 200% growth in business capacity. In addition to his humanitarian work, Omar has supported and collaborated with organizations globally in a consultant capacity, attaining multiple winning deals, reducing costs, and expanding regionally.

Omar is currently heading the operations at the Clinical Biomanufacturing Facility, Pandemic Sciences Institute, University of Oxford, handling the general management and collaborating with the Head of the Clinical Biomanufacturing Facility and the University’s Senior Leadership in developing and implementing the business strategy, identifying objectives, opportunities, risks, and priorities, and advising on the practicability of proposed strategic directions.

 As recognition for his efforts, Omar is one of the recipients of the Copley Medal 2022, awarded to the Oxford-AstraZeneca Vaccine Team by the Royal Society, the Society's oldest and most prestigious prize. In addition to this, the team was awarded many other awards and prizes, including The GQ Men of the Year 2021: Heroes of the Year Award; The Pride of Britain 2021: Special Recognition Award; The Queen’s Anniversary Prize 2022; and the 2020 NHS Parliamentary Awards: The Excellence in Healthcare Award.


Master's Degree (International Executive MBA) from The Kellogg School of Management at Northwestern University, IL, USA

Master's Degree (Biotech and Pharmaceutical Management MSc) from the Global Business School for Health at UCL, London, UK (Expected 2024)

BSc. Degree in Mechatronics Engineering from the University of Jordan, Amman, Jordan